{
    "2021-01-18": [
        [
            {
                "time": "",
                "original_text": "医药生物：中国创新药是否到了国际化的拐点？",
                "features": {
                    "keywords": [
                        "创新药",
                        "国际化",
                        "拐点"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：龙头普遍回调，关注轮动机会",
                "features": {
                    "keywords": [
                        "龙头回调",
                        "轮动机会"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业政策点评：第四批集采开标在即 持续看好创新药及相关产业链",
                "features": {
                    "keywords": [
                        "集采",
                        "创新药",
                        "产业链"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：珍惜短期“抱团股”调整 持续推荐“创新+自主消费”",
                "features": {
                    "keywords": [
                        "抱团股",
                        "调整",
                        "创新",
                        "自主消费"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国君策略：A股市场已出现蓝筹泡沫 南下策略重要性凸显",
                "features": {
                    "keywords": [
                        "蓝筹泡沫",
                        "南下策略"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物：CXO景气度持续高涨 重点推荐药明康德、凯莱英等",
                "features": {
                    "keywords": [
                        "CXO",
                        "景气度",
                        "药明康德",
                        "凯莱英"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-01-11至2021-01-15",
                "original_text": "第四轮国采正式启动，国常会首提集采要兼顾企业利润 -- 兴证海外医药周报（2021.1.11-1.15）",
                "features": {
                    "keywords": [
                        "国采",
                        "企业利润",
                        "政策"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}